Search Results for 'biopharma'

Search For:
Refine by Dates:
From: To:
Refine By Content:

  • Healthcare Deform

    Gil Y. Roth || September 3, 2009
    I've done a bang-up job of staying out of this summer's rancorous "debates" over healthcare reform, and plan to stay on that path. So don't try to get me wound up. The thing is, I don't doubt the sincerity of citizens on both sides of the is…

  • Alder Biopharmaceuticals

    August 12, 2009
    Mark D. Young, Ph.D. has been named senior vice president of Pharmaceutical Operations at Alder Biopharmaceuticals

  • 03 Novo Nordisk

    03 Novo Nordisk

    July 23, 2009
    #3 Novo Nordisk Novo Allé, 2880 Bagsværd, Denmark Tel: (45) 4444-8888 Fax: (45) 4449-0555 www.novonordisk.com Headcount 27,000   Year Established 1989  …

  • 08 Roche

    08 Roche

    July 22, 2009
    #8 Roche Grenzacherstrasse 124, CH-4070 Basel, Switzerland Tel: (41) 61 688 1111 Fax: (41) 61 691 9391 www.roche.com Headcount 80,080   Year Established 1896  …

  • 04 Merck Serono

    04 Merck Serono

    July 16, 2009
    #4 Merck Serono Frankfurter Str. 250, D-64293 Darmstadt Germany Tel: (49) 6151-72-0 Fax: (49) 6151-72-2000 www.merck.de Headcount 32,800   Year Established 1668  …

  • 11 Wyeth

    11 Wyeth

    July 16, 2009
    #11 Wyeth Five Giralda Farms, Madison, NJ 07940 Tel: (973) 660-5000 Fax: (973) 660-7026 www.wyeth.com Headcount 47,426   Year Established 1926   Pharma Reve…

  • 10 Bristol-Myers Squibb

    10 Bristol-Myers Squibb

    July 16, 2009
    #10 Bristol-Myers Squibb 345 Park Ave., New York, NY 10154-0037 Tel: (212) 546-4000 Fax: (212) 546-4020 www.bms.com Headcount 35,000   Year Established 1887  …

  • Generic Matters

    Gil Roth || July 15, 2009
    How do we keep up with the changing times?

  • 2009 Top 10 Biopharmaceutical Companies Report

    2009 Top 10 Biopharmaceutical Companies Report

    July 15, 2009
    This edition of the Top 10 Biopharmas marks the end of an era. After this year, we’ll no longer be able to pencil in Amgen as our #1 biopharma, since Roche is poised to take that slot. A lot of major pharmas have talked about “becoming a global biopharma.

  • 2009 Top 20 Pharmaceutical Companies Report

    2009 Top 20 Pharmaceutical Companies Report

    July 15, 2009
    They don’t call them “Big Pharma” for nothing! Several of the industry’s biggest players decided to get bigger via M&A this year, which means next year’s ranks are going to feature at least three new players, once Wyeth and Schering-Plough are swallowed up and Roche moves over to the Top Biopharma ranks. And I do mean top!

  • 01 Amgen

    01 Amgen

    July 15, 2009
    #1 Amgen One Amgen Center Dr., Thousand Oaks, CA 91320-1799 Tel: (805) 447-1000 Fax: (805) 447-1010 www.amgen.com Headcount 17,000   Year Established 1980  …

  • 02 Genentech

    02 Genentech

    July 9, 2009
    #2 Genentech 1 DNA Way, South San Francisco, CA 94080 Tel: (650) 225-1000 Fax: (650) 225-6000 www.gene.com Headcount 11,000   Year Established 1976   Biopha…

  • 01 Pfizer

    01 Pfizer

    July 9, 2009
    #1 - Pfizer 235 E. 42nd St. New York, NY 10017-5755 Tel: (212) 573-2323 Fax: (212) 573-7851 www.pfizer.com Headcount 81,800   Year Established 2000   Phar…

  • 06 Biogen Idec

    06 Biogen Idec

    July 8, 2009
    #6 Biogen Idec 14 Cambridge Center, Cambridge, MA 02142 Tel: (617) 679-2000 Fax: (617) 679-2617 www.biogenidec.com Headcount 4,700   Year Established 2003  …

  • 03 GlaxoSmithKline

    03 GlaxoSmithKline

    July 8, 2009
    #3 GSK 980 Great West Rd. Brentford, Middlesex TW8 9GS, UK Tel: (44) 020 8047 5000 Fax: (44) 020 8047 7807 www.gsk.com Headcount 99,003   Year Established 2002  …

  • Clinical Trial Imaging

    Clinical Trial Imaging

    Kristin Brooks || June 3, 2009
    Innovation, trends and challenges

  • CRO Industry Update

    CRO Industry Update

    Kristin Brooks || June 3, 2009
    Opportunities in uncertain times

  • Classic Lines of Bull

    Dave Jensen || June 3, 2009
    Say what you mean

  • 2009 Annual Outsourcing Survey

    2009 Annual Outsourcing Survey

    Gil Roth, Editor || May 15, 2009
    Welcome to our 5th Annual Contract Pharma Outsourcing Survey! More than 175 sponsor-side respondents offered up their opinions on outsourcing trends for this year's poll. Here's a breakdown of respondents by company type:

  • 2009 Annual Outsourcing Survey

    2009 Annual Outsourcing Survey

    Gil Roth || May 5, 2009
    window.location="http://www.contractpharma.com/contents/view_outsourcing-survey/2009-05-15/2009-annual-outsourcing-survey-561099/"…

  • Also in This Issue

    Also in This Issue

    Gil Roth || May 4, 2009
    More features and columns in our print edition

  • How Similar Must Biosimilars Be?

    Ed Silverman || May 4, 2009
    Follow-on biologics are on their way

  • Capacity Utilization & Capacity Constraints

    Capacity Utilization & Capacity Constraints

    Eric S. Langer || May 4, 2009
    Trends and differences in the U.S. & Western Europe

  • Biopharma CMO Market Report

    Biopharma CMO Market Report

    William Downey || May 1, 2009
    Optimism remains high among bio-contract manufacturers

  • Mitigating Risk in the Biomaterial Cold Chain

    Mitigating Risk in the Biomaterial Cold Chain

    Jeff Clark || May 1, 2009
    Cold chain management is essential in biopharma development

  • Novozymes Biopharma Builds cGMP bHA Facility

    April 27, 2009
    Novozymes Biopharma has begun construction of a new cGMP facility at its existing site in Tianjin, China, enabling the company to produce Bacillus-based Hyaluronic Acid (bHA), HyaCare, for the bio-medical and pharmaceutical industries.

  • Also in this issue

    Also in this issue

    Gil Roth || April 2, 2009
    More features and columns in our print edition

  • BIOTECH FAIL?

    Gil Roth || April 1, 2009
    With bio-financing tight, can service providers find new models?

  • OSO BioPharmaceuticals

    March 25, 2009
    Dr. Suman Kathuria has been appointed vice president of quality, OSO BioPharmaceuticals Manufacturing, LLC.

  • Success in Partnerships

    Success in Partnerships

    Pedram Alaedini and Howard Kim || March 4, 2009
    Success in Partnerships

  • Merger Mania?

    Ed Silverman || March 4, 2009
    Our new columnist speculates on the Pfizer/Wyeth fallout

  • Big Questions in 2009

    Gil Roth || January 22, 2009
    Short takes on the world at large

  • OSO BioPharmaceuticals Manufacturing

    January 22, 2009
    Rick Lapointe has been appointed vice president of technology and acquisitions at OSO BioPharmaceuticals Manufacturing. Mr. Lapointe will be responsible for working with the senior leadership team to increase the company’s capabilities, identif…

  • The Preclinical Year in Review

    Steve Snyder || November 6, 2008
    A look back at 2008

  • Bio News & Views: Bio-Outsourcing Trends

    Eric S. Langer || November 6, 2008
    Bio News & Views: Bio-Outsourcing Trends A new study explores capacity and production issues By Eric S. Langer Outsourcing biopharmaceutical production has become increasingly common during the past decade, with more than half of…

  • Vaccine Viewpoint

    Vaccine Viewpoint

    Gil Roth || November 6, 2008
    Michael Kowolenko of Wyeth talks about the convergence of vaccines and biotech

  • API Risk Communication Case History

    API Risk Communication Case History

    Jim Lieberman, CIH || November 6, 2008
    Building a potent compound matrix to communicate with CMOs

  • Facts and Myths about EPS

    Kevin O'Donnell || October 3, 2008
    More than just packing peanuts

  • A New Wave of Collaborations

    Michael Martorelli || October 3, 2008
    Working together is a good idea

  • USP Changes

    USP Changes

    John Daniels || October 3, 2008
    Are you ready?

  • Air Cargo Screening: A New Mandate

    Kevin O'Donnell || September 4, 2008
    Additional risk to time- and temperature-sensitive freight?

  • BMS, PDL BioPharma Enter Multiple Myeloma Drug Pact

    August 20, 2008
    Bristol-Myers Squibb and PDL BioPharma, Inc. entered an agreement for the global development and commercialization of PDL’s anti-CS1 antibody, elotuzumab, currently in Phase I development for multiple myeloma.     Elotuzumab o…

  • 2008 Top 20 Pharmaceutical Companies Report

    2008 Top 20 Pharmaceutical Companies Report

    July 18, 2008
    The weak U.S. dollar played a strong role in this year’s Top 20 Pharma Report. Several overseas players look a lot better than they should, thanks to my insistence on converting all results to dollars. In local currencies, many foreign and domestic players were barely able to eke out growth in 2007.

  • 2008 Top 10 Biopharmaceutical Companies Report

    2008 Top 10 Biopharmaceutical Companies Report

    July 18, 2008
    After years of producing this report, I’ve finally settled on definitive criteria for the Top Biopharma ranks! After consulting with Ronald A. Rader, president of the Biotechnology Information Institute, I decided that a Top Biopharma company is one that makes more than 40% of its drug revenues by selling biologic products, including biotherapeutics, vaccines and other proteins.

  • Biogen Idec

    July 17, 2008
    #6 Biogen Idec 14 Cambridge Center, Cambridge, MA 02142 Tel: (617) 679-2000 Fax: (617) 679-2617 www.biogenidec.com Headcount 4,200   Year Esta…

  • Baxter BioScience

    July 17, 2008
    #5 Baxter BioScience One Baxter Parkway Deerfield, IL 60015 Tel: (847) 948-2000 Fax: (847) 948-3642 www.baxter.com Headcount 46,500 (total company) …

  • Merck Serono

    July 17, 2008
    #4 Merck Serono Frankfurter Str. 250, D-64293 Darmstadt Germany Tel: (49) 6151-72-0 Fax: (49) 6151-72-2000 www.merck.de Headcount 30,968   Yea…

  • Novo Nordisk

    July 17, 2008
    #3 Novo Nordisk Novo Allé, 2880 Bagsværd, Denmark Tel: (45) 4444-8888 Fax: (45) 4449-0555 www.novonordisk.com Headcount 26,000+  …

  • Genentech

    July 17, 2008
    #2 Genentech 1 DNA Way, South San Francisco, CA 94080 Tel: (650) 225-1000 Fax: (650) 225-6000 www.gene.com Headcount 11,000   Year Established…

  • Amgen

    July 17, 2008
    #1 Amgen One Amgen Center Dr., Thousand Oaks, CA 91320-1799 Tel: (805) 447-1000 Fax: (805) 447-1010 www.amgen.com Headcount 17,500   Year Esta…